class="wp-theme-Newspaper supp-body td-standard-pack global-block-template-1 tdc-header-template tdc-footer-template td-animation-stack-type0 td-full-layout"
Anticoagulant interaction: structural similarity to heparin — mild anticoagulant activity. Warfarin: INR increase reported. Shellfish/bovine source considerations. Allergy to source material. Generally well tolerated at recommended doses.
Glycosaminoglycan from bovine, porcine, or marine cartilage. Used for osteoarthritis, particularly in combination with glucosamine. Inhibits inflammatory enzymes and promotes proteoglycan synthesis.
Acts on cellular signalling pathways relevant to the documented clinical indications. Contains bioactive compounds with enzyme-modulating, receptor-binding, or antioxidant properties studied in peer-reviewed literature.
| Population | Safety rating | Max safe dose |
|---|---|---|
| General | Possibly safe | — |
| Pregnancy | Possibly safe | — |
| Elderly | Possibly safe | — |
No peer-reviewed clinical trial data found for this ingredient.
Data by supplement.ge — Public Health Institute of Georgia (PHIG)